Sarcoidosis associated with interferon-α therapy for chronic hepatitis C

被引：0
|
作者：
Papaioannides, D
Fotinou, M
Korantzopoulos, P
Latsi, P
Sinapidis, D
Akritidis, N
Orphanidou, D
机构：
[1] Arta Gen Hosp, Dept Med, Arta, Greece
[2] Sotiria Hosp, Dept Pathol, Athens, Greece
[3] Univ Athens, Sch Med, Sotiria Hosp, Dept Resp Med, Athens, Greece
来源：
MEDICAL SCIENCE MONITOR | 2004年 / 10卷 / 01期
关键词：
IFN-alpha; interferon-alpha; SACE-serum angiotensin converting enzyme;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Recombinant interferon-alpha (IFN-alpha) is widely used for the treatment of chronic hepatitis C. Pulmonary side effects of IFN-alpha therapy seem to be rare. So far, only a few cases of sarcoidosis in association with IFN-a treatment of chronic hepatitis C have been reported. A 52-year-old woman with chronic hepatitis C developed sarcoidosis during treatment with IFN-alpha. Diagnosis of sarcoidosis was based on chest imaging studies, the increased serum angiotensin converting enzyme levels, and the histology of a biopsied cervical lymph node. Spontaneous remission was observed following IFN-alpha withdrawal. Use of recombinant IFN-alpha in patients with chronic hepatitis C may trigger or contribute to the development of sarcoidosis in susceptible individuals. Patients should be monitored during and following IFN-alpha therapy for the occurrence of manifestations suggesting sarcoidosis.
引用
收藏
页码：CS5 / CS7
页数：3
相关论文
共 50 条
  • [1] Sarcoidosis associated with interferon-α therapy for chronic hepatitis C
    Hoffmann, RM
    Jung, MC
    Motz, R
    Gössl, C
    Emslander, HP
    Zachoval, R
    Pape, GR
    JOURNAL OF HEPATOLOGY, 1998, 28 (06) : 1058 - 1063
  • [2] Probable cutaneous sarcoidosis associated with combined interferon-α and ribavirin therapy for chronic hepatitis C
    Savoye, G
    Goria, O
    Herve, S
    Riachi, G
    Noblesse, I
    Bastien, L
    Courville, P
    Lerebours, E
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2000, 24 (6-7): : 679 - 680
  • [3] Sarcoidosis, chronic hepatitis C and interferon-α:: Two cases
    Luchi, S
    Scasso, A
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 (10) : 775 - 776
  • [4] Uterine sarcoidosis potentially associated with interferon-α use for chronic hepatitis C infection
    Tsiodras, S
    Drimala, P
    Dacmythras, M
    Alamani, AM
    Naoum, G
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (05): : 1198 - 1201
  • [5] Sarcoidosis occurring after interferon-α therapy for chronic hepatitis C:: Report of two cases
    Hirano, A
    Kataoka, M
    Nakata, Y
    Takeda, K
    Kamao, T
    Hiramatsu, J
    Kimura, G
    Tanimoto, Y
    Kanehiro, A
    Tanimoto, M
    RESPIROLOGY, 2005, 10 (04) : 529 - 534
  • [6] Pernicious anemia associated with interferon-α therapy and chronic hepatitis C infection
    Andrés, E
    Loukili, NH
    Ben Abdelghani, M
    Noel, E
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (04) : 382 - 382
  • [7] Interferon-α therapy associated with the development of sarcoidosis
    Pietropaoli, A
    Modrak, J
    Utell, M
    CHEST, 1999, 116 (02) : 569 - 572
  • [8] Pericarditis After Therapy with Interferon-α for Chronic Hepatitis C
    A. Boonen
    R. W. Stockbrügger
    Sj. van der Linden
    Clinical Rheumatology, 1999, 18 : 177 - 179
  • [9] Pericarditis after therapy with interferon-α for chronic hepatitis C
    Boonen, A
    Stockbrügger, RW
    van der Linden, S
    CLINICAL RHEUMATOLOGY, 1999, 18 (02) : 177 - 179
  • [10] Interferon-associated retinopathy in a uniform regimen of natural interferon-α therapy for chronic hepatitis C
    Saito, H
    Ebinuma, H
    Nagata, H
    Inagaki, Y
    Saito, Y
    Wakabayashi, K
    Takagi, T
    Nakamura, M
    Katsura, H
    Oguchi, Y
    Ishii, H
    LIVER, 2001, 21 (03): : 192 - 197
12345